Search

Your search keyword '"de Bont, Eveline S.J.M."' showing total 197 results

Search Constraints

Start Over You searched for: Author "de Bont, Eveline S.J.M." Remove constraint Author: "de Bont, Eveline S.J.M."
197 results on '"de Bont, Eveline S.J.M."'

Search Results

52. Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3

55. RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML

56. Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair

58. VEGFC Antibody Therapy Drives Differentiation of AML

61. Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study

63. Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma

65. Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

66. A First Step toward Personalized Medicine in Osteosarcoma: Pharmacogenetics as Predictive Marker of Outcome after Chemotherapy-Based Treatment

70. Impact of Additional Cytogenetic Abnormalities and Variant t(9;22) at Diagnosis on Prognosis of Childhood Chronic Myelogenous Leukemia : The Experience of the International Registry for CML in Children and Adolescents (I-CML-Ped Study)

71. The Experience of the International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped Study): Pronostic Consideration

72. Weight and height in children newly diagnosed with cancer

74. Association of genetic variants involved in drug metabolism and transport with efficacy and toxicity of chemotherapeutic treatment in osteosarcoma patients.

75. Kinome profiling in pediatric brain tumors as a new approach for target discovery

76. Identification of distinct protein Signatures Associated with genetic Abnormalities In Acute Lymphoblastic Leukemia

77. Pharmacokinetic Results Of a Feasibility and Phase II Study (ITCC 021) On Bortezomib (BTZ) In Pediatric Relapsed ALL: Lack Of Significant Penetration Of BTZ In The Cerebrospinal Fluid

80. EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion

83. Abstract 3209: Gene expression micro array analysis of diagnosis and matched relapse pediatric AML samples indicates that immune regulatory pathways and epigenetic factors are involved in disease progression

89. Overexpression of BRE in Pediatric MLL-Rearranged Acute Myeloid Leukemia Associated with t(9;11)(p22;q23).

90. Frequent Instability of Type I and II Aberrations Between Diagnosis and Relapse Observed in Pediatric Aml; Implications for Targeted Therapy and MRD Detection.

92. Kinome Profiling in Pediatric Brain Tumors as a New Approach for Target Discovery

93. Identification of Gene Expression Signatures Accurately Predicting Cytogenetic Subtypes in Pediatric Acute Myeloid Leukemia.

94. Endogenous Vascular Endothelial Growth Factor-C Expression Is Associated with Decreased Drug Responsiveness in Childhood Acute Myeloid Leukemia

95. Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell death

97. In Reply

Catalog

Books, media, physical & digital resources